Carcinoma of minor salivary glands.

  • HINO Takeshi
    The Japanese Joint Committee on TNM Classification, the Head and Neck Subcommittee, the Salivary Gland Division Department of Otorhinolaryngology, School of Medicine, Chiba University
  • YUZA Jun
    The Japanese Joint Committee on TNM Classification, the Head and Neck Subcommittee, the Salivary Gland Division Department of Otorhinolaryngology, School of Medicine, Chiba University
  • NUMATA Tsutomu
    The Japanese Joint Committee on TNM Classification, the Head and Neck Subcommittee, the Salivary Gland Division Department of Otorhinolaryngology, School of Medicine, Chiba University
  • HAYASAKI Katsutake
    The Japanese Joint Committee on TNM Classification, the Head and Neck Subcommittee, the Salivary Gland Division Division of Otorhinolaryngology, Labour Welfare Corporation Chiba Rousai Hospital
  • KONNO Akiyoshi
    The Japanese Joint Committee on TNM Classification, the Head and Neck Subcommittee, the Salivary Gland Division Department of Otorhinolaryngology, School of Medicine, Chiba University

Bibliographic Information

Other Title
  • 小唾液腺癌症例の全国集計

Search this article

Description

Between 1980 and 1994, a total of 201 patients with carcinoma of minor salivary glands were documented by the Salivary Gland Division of the Head and Neck Subcommittee of the Japanese Joint Committee on TNM Classification. There were 80 males and 121 females, ranging in age from 12 to 90 years. The hard palate was the most common site of origin (36.7%). This was followed by floor of mouth (13.4%), mucosal surface of cheeck (10.4%), inferior surface of soft palate (9.5%), retromolar areas (7.5%). When these patients were staged according to TNM classification (UICC 1987, Geneva), 81 (40.3%), 69 (34.3%), 23 (11.4%) and 28 (13.9%) had staged I to IV of the disease, respectively. At the time of diagnosis, 22 (10.9%) patients had metastases to the regional lymph nodes and 6 (3.0%) had distant metastases. Mucoepidermoid carcinoma was the histologic type most frequently encounterd in this series (43.8%). Adenoid cystic carcinoma was seen in 33.8% of these patients. Crude 5-year survival rate was 73.9%.

Journal

Citations (14)*help

See more

References(14)*help

See more

Details 詳細情報について

Report a problem

Back to top